1549 results for Leukemia
Refine Your Search
The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting
San Diego, December , – Using the latest genetic tools, Elvin Wagenblast, Ph.D., is dissecting blood cells to explain exactly why and how some go fr…
News Release
The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care
LLS’s Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care an…
News Release
Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night
Rye Brook, NY, March , – The Leukemia & Lymphoma Society (LLS) announced today that BeiGene, Ltd., a global oncology company, has signed a partnersh…
LLS Announces Collaboration with the National Cancer Institute and Children’s Oncology Group on a Global Master Clinical Trial for Children with Acute Leukemia
June , (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Child…
LLS ANNOUNCES COLLABORATION WITH THE NATIONAL CANCER INSTITUTE AND CHILDREN’S ONCOLOGY GROUP ON A GLOBAL MASTER CLINICAL TRIAL FOR CHILDREN WITH ACUTE LEUKEMIA
June , (Rye Brook, NY) - The Leukemia & Lymphoma Society (LLS) announced today a collaboration with the National Cancer Institute (NCI) and the Child…
News Release
Kymera Therapeutics Presents Data Demonstrating Superior Efficacy of KT-253, a Potent and Selective Heterobifunctional MDM2 Degrader, in Preclinical Leukemia Models at the European Hematology Association Congress
WATERTOWN, Mass., June , - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation (TPD) to del…
White House Highlights The Leukemia & Lymphoma Society’s Efforts to Bring Clinical Trials and Treatment Innovation to Diverse and Underrepresented Communities Nationwide in Alignment with the Biden-Harris Administration's Cancer Moonshot
LLS’s Investment in Research Aims to Accelerate Treatment Innovation and Expand Equitable Access to Treatments to Increase the Quality of Life and Su…
Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was previously known as natural killer (NK) cell leukemia/lymphoma. In , as the understanding of…
Blood Cancer
Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML) Facts
This fact sheet provides information about CMML and JMML diagnoses, treatment, clinical trials, and support resources.
Hairy Cell Leukemia
This fact sheet provides information about hairy cell leukemia, including symptoms, diagnosis and treatment.
Chronic Neutrophilic Leukemia
This fact sheet provides information about diagnosis, treatment, expected outcomes and available support resources for chronic neutrophilic leukemia (CNL).
Understanding AML vs. ALL: Navigating the complex field
Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…
LYMPHOMA: WHAT MAKES THIS BLOOD CANCER SO DIFFERENT?
September is Blood Cancer Awareness Month and The Leukemia & Lymphoma Society (LLS) is increasing awareness about the urgency to find cures for blood …
Chronic Lymphocytic Leukemia: In Detail
This booklet provides detailed information about chronic lymphocytic leukemia (CLL) for patients and their families. For an easier-to-read version, see CLL: The Basics.
Chronic Myeloid Leukemia: In Detail
This booklet provides information about chronic myeloid leukemia (CML) for people who have CML and their families.
For an easier-to-read version, see CML: The Basics.
Count on LLS this Blood Cancer Awareness Month
September is Blood Cancer Awareness Month, and The Leukemia & Lymphoma Society is leading the way in blood cancer support, research, and advocacy.
Facts About Pediatric Acute Leukemia
FOR HEALTHCARE PROFESSIONALS: This fact sheet has been developed to provide essential knowledge regarding diagnosis, treatment, clinical trials, and long-term management, as well as key resources to help patients and families along this lifetime healthcare journey.
Acute Lymphoblastic Leukemia (ALL) in Adults
This booklet provides information about acute lymphoblastic leukemia (ALL) for patients and their families.
Acute Myeloid Leukemia in Adults: In Detail
This book provides detailed information about acute myeloid leukemia (AML) in adults.
What I’ve Learned: Tips for Parents of Kids with ALL
My daughter Mackenzie was diagnosed with acute lymphoblastic leukemia (ALL) in January . Despite being the most common form of childhood cancer that h…
Blog